Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule, AB001.
[Agastiya Biotech (Cision US, Inc.)]
Home Newsletters Extracellular Matrix News Agastiya Biotech Receives FDA Orphan Drug Designation for AB001 for Pancreatic Cancer...
